Description

T-type calcium channel (Cav3.x) structure and phytocannabinoid inhibition sites. T-type channels are critically involved in thalamocortical oscillations underlying absence seizures.

Figure 221

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 221: T-type calcium channel (Cav3.x) structure and phytocannabinoid inhibition sites. T-type channels are critically involved in thalamocortical oscillations underlying absence seizures.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="T-type calcium channel (Cav3.x) structure and phytocannabinoid inhibition sites. T-type channels are critically involved in thalamocortical oscillations underlying absence seizures." />
  <figcaption>Figure 221. T-type calcium channel (Cav3.x) structure and phytocannabinoid inhibition sites. T-type channels are critically involved in thalamocortical oscillations underlying absence seizures.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Preuves associées

CBD pour Insomnie

Note A · 103 études